The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Kurian, Gino A ^a   Rajagopal, Rashmi ^a   Vedantham, Srinivasan ^a   Rajesh, Mohanraj ^b  

^a SASTRA UNIVERSITY   (India)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; DRUG THERAPY;

ANTIOXIDANT DEFENSE; CARDIO-VASCULAR DISEASE; DIABETIC CARDIOMYOPATHY; EXPERIMENTAL EVIDENCE; MYOCARDIAL INFRACTION; MYOCARDIAL ISCHEMIA; REACTIVE OXYGEN SPECIES; SUBCELLULAR ORGANELLES;

DISEASES;

CAPTOPRIL; CELIPROLOL; FLUINDOSTATIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROGEN SULFIDE; INDACATEROL; METOPROLOL; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PRANIDIPINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SINAPIC ACID; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; VILDAGLIPTIN;

APOPTOSIS; CELLULAR STRESS RESPONSE; DIABETIC CARDIOMYOPATHY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENESIS; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HEART VENTRICLE REMODELING; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PHYSIOLOGY;

ANIMALS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; VENTRICULAR REMODELING;

EID: 84975165468     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1656450     Document Type: Review

References (136)

1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., "Heart disease and stroke statistics-2015 update : a report from the American Heart Association," Circulation, vol. 131, no. 4, pp. e29-e39, 2015.
2. C. X. C. Santos, N. Anilkumar, M. Zhang, A. C. Brewer, and A. M. Shah, "Redox signaling in cardiac myocytes," Free Radical Biology and Medicine, vol. 50, no. 7, pp. 777-793, 2011.
3. M. S. Willis and C. Patterson, "Proteotoxicity and cardiac dysfunction-Alzheimer's disease of the heart?" The New England Journal of Medicine, vol. 368, no. 5, pp. 455-464, 2013.
4. E. S. Christians and I. J. Benjamin, "Proteostasis and REDOX state in the heart," American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 1, pp. H24-H37, 2012.
5. J. Navarro-Yepes, M. Burns, A. Anandhan et al., "Oxidative stress, redox signaling, and autophagy: cell death versus survival," Antioxidants and Redox Signaling, vol. 21, no. 1, pp. 66-85, 2014.
6. R. Ferrari, O. Alfieri, S. Curello et al., "Occurrence of oxidative stress during reperfusion of the human heart," Circulation, vol. 81, no. 1, pp. 201-211, 1990.
7. O. Zitka, S. Skalickova, J. Gumulec et al., "Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients," Oncology Letters, vol. 4, no. 6, pp. 1247-1253, 2012.
8. C. Kupatt, R. Hinkel, J. Horstkotte et al., "Selective retroinfusion of GSH and cariporide attenuates myocardial ischemiareperfusion injury in a preclinical pig model," Cardiovascular Research, vol. 61, no. 3, pp. 530-537, 2004.
9. P. L. Wendell, "Measurement of oxidized glutathione and total glutathione in the perfused rat heart," Biochemical Journal, vol. 117, no. 4, pp. 661-665, 1970.
10. M. A. Aon, S. Cortassa, C. Maack, and B. O'Rourke, "Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status," Journal of Biological Chemistry, vol. 282, no. 30, pp. 21889-21900, 2007.
11. P. Das, K. K. Nutan, S. L. Singla-Pareek, and A. Pareek, "Oxidative environment and redox homeostasis in plants: dissecting out significant contribution of major cellular organelles," Frontiers in Environmental Science, vol. 2, article 70, 2015.
12. C. Penna, D. Mancardi, R. Rastaldo, and P. Pagliaro, "Cardioprotection: a radical view: free radicals in pre and postconditioning," Biochimica et Biophysica Acta (BBA)-Bioenergetics, vol. 1787, no. 7, pp. 781-793, 2009.
13. H. Wiseman and B. Halliwell, "Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer," Biochemical Journal, vol. 313, no. 1, pp. 17-29, 1996.
14. E. Roche and D. Romero-Alvira, "Role of oxidative stress in gene expression:myocardial and cerebral ischemia, cancer and other diseases," Medicina Clinica, vol. 104, no. 12, pp. 468-476, 1995.
15. P. Venditti, P. Masullo, and S. Di Meo, "Effects of myocardial ischemia and reperfusion on mitochondrial function and susceptibility to oxidative stress," Cellular and Molecular Life Sciences, vol. 58, no. 10, pp. 1528-1537, 2001.
16. J. F. Keaney Jr. and J. A. Vita, "Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action," Progress in Cardiovascular Diseases, vol. 38, no. 2, pp. 129-154, 1995.
17. R. A. Thandavarayan, V. V. Giridharan, K. Watanabe, and T. Konishi, "Diabetic cardiomyopathy and oxidative stress: role of antioxidants," Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 9, no. 4, pp. 225-230, 2011.
18. D. F. Stowe and A. K. S. Camara, "Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function," Antioxidants & Redox Signaling, vol. 11, no. 6, pp. 1373-1414, 2009.
19. A. K. S. Camara, E. J. Lesnefsky, and D. F. Stowe, "Potential therapeutic benefits of strategies directed to mitochondria," Antioxidants and Redox Signaling, vol. 13, no. 3, pp. 279-347, 2010.
20. C. B. Wolff, "Normal cardiac output, oxygen delivery and oxygen extraction," Advances in Experimental Medicine and Biology, vol. 599, pp. 169-182, 2007.
21. B. Gopalakrishnan, K. M. Nash, M. Velayutham, and F. A. Villamena, "Detection of nitric oxide and superoxide radical anion by electron paramagnetic resonance spectroscopy from cells using spin traps," Journal of Visualized Experiments, no. 66, article e2810, 2012.
22. S. Raha, G. E. McEachern, A. T. Myint, and B. H. Robinson, "Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase," Free Radical Biology and Medicine, vol. 29, no. 2, pp. 170-180, 2000.
23. E. Ho, K. Karimi Galougahi, C.-C. Liu, R. Bhindi, and G. A. Figtree, "Biological markers of oxidative stress: applications to cardiovascular research and practice," Redox Biology, vol. 1, no. 1, pp. 483-491, 2013.
24. C.M. Arroyo, J. H. Kramer, B. F. Dickens, and W. B. Weglicki, "Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO," FEBS Letters, vol. 221, no. 1, pp. 101-104, 1987.
25. K. Carvajal, M. El Hafidi, and G. Baños, "Myocardial damage due to ischemia and reperfusion in hypertriglyceridemic and hypertensive rats: participation of free radicals and calcium overload," Journal of Hypertension, vol. 17, no. 11, pp. 1607-1616, 1999.
26. G. A. Kurian and J. Paddikkala, "Administration of aqueous extract of Desmodium gangeticum (L) root protects rat heart against ischemic reperfusion injury induced oxidative stress," Indian Journal of Experimental Biology, vol. 47, no. 2, pp. 129-135, 2009.
27. G. A. Kurian, S. Suryanarayanan, A. Raman, and J. Padikkala, "Antioxidant effects of ethyl acetate extract of Desmodium gangeticum root on myocardial ischemia reperfusion injury in rat hearts," Chinese Medicine, vol. 5, article 3, 2010.
28. G. A. Kurian and J. Paddikkala, "N-acetylcysteine and magnesium improve biochemical abnormalities associated with myocardial ischaemic reperfusion in South Indian patients undergoing coronary artery bypass grafting: a comparative analysis," Singapore Medical Journal, vol. 51, no. 5, pp. 381-388, 2010.
29. F. J. Giordano, "Oxygen, oxidative stress, hypoxia, andheart failure," The Journal of Clinical Investigation, vol. 115, no. 3, pp. 500-508, 2005.
30. B. R. Lucchesi, "Myocardial ischemia, reperfusion and free radical injury," The American Journal of Cardiology, vol. 65, no. 19, pp. 14-23, 1990.
31. C. Tanaka-Esposito, Q. Chen, and E. J. Lesnefsky, "Blockade of electron transport before ischemia protects mitochondria and decreases myocardial injury during reperfusion in aged rat hearts," Translational Research, vol. 160, no. 3, pp. 207-216, 2012.
32. A. K. Gadicherla, D. F. Stowe, W. E. Antholine, M. Yang, and A. K. S. Camara, "Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine," Biochimica et Biophysica Acta-Bioenergetics, vol. 1817, no. 3, pp. 419-429, 2012.
33. G. Paradies, G. Petrosillo, M. Pistolese, and F. M. Ruggiero, "Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage," Gene, vol. 286, no. 1, pp. 135-141, 2002.
34. J.W. Palmer, B. Tandler, and C.L. Hoppel, "Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle," Journal of Biological Chemistry, vol. 252, no. 23, pp. 8731-8739, 1977.
35. S. A. Banu, S. Ravindran, and G. A. Kurian, "Hydrogen sulfide post-conditioning preserves interfibrillar mitochondria of rat heart during ischemia reperfusion injury," Cell Stress and Chaperones, 2016.
36. B. Chance, H. Sies, and A. Boveris, "Hydroperoxide metabolism in mammalian organs," Physiological Reviews, vol. 59, no. 3, pp. 527-605, 1979.
37. C. Crochemore, M. Mekki, C. Corbière et al., "Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles," Free Radical Research, vol. 49, no. 3, pp. 331-337, 2015.
38. G. A. Kurian, E. Berenshtein, A. Saada, and M. Chevion, "Rat cardiac mitochondrial sub-populations show distinct features of oxidative phosphorylation during ischemia, reperfusion and ischemic preconditioning," Cellular Physiology and Biochemistry, vol. 30, no. 1, pp. 83-94, 2012.
39. G. A. Kurian, E. Berenshtein, O. Kakhlon, and M. Chevion, "Energy status determines the distinct biochemical and physiological behavior of interfibrillar and sub-sarcolemmal mitochondria," Biochemical and Biophysical Research Communications, vol. 428, no. 3, pp. 376-382, 2012.
40. A. Lejay, F. Fang, R. John et al., "Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus," Journal of Molecular and Cellular Cardiology, vol. 91, pp. 11-22, 2016.
41. H. S. Chung, S.-B. Wang, V. Venkatraman, C. I. Murray, and J. E. Van Eyk, "Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system," Circulation Research, vol. 112, no. 2, pp. 382-392, 2013.
42. H. S. Chung, C. I. Murray, V. Venkatraman et al., "Dual labeling biotin switch assay to reduce bias derived from different cysteine subpopulations: a method to maximize s-nitrosylation detection," Circulation Research, vol. 117, no. 10, pp. 846-857, 2015.
43. M. Talkhabi, N. Aghdami, and H. Baharvand, "Human cardiomyocyte generation from pluripotent stem cells: a state-ofart," Life Sciences, vol. 145, pp. 98-113, 2016.
44. O. Bergmann, S. Zdunek, A. Felker et al., "Dynamics of cell generation and turnover in the human heart," Cell, vol. 161, no. 7, pp. 1566-1575, 2015.
45. C. Jopling, E. Sleep, M. Raya, M. Martí, A. Raya, and J. C. I. Belmonte, "Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation," Nature, vol. 464, no. 7288, pp. 606-609, 2010.
46. E. R. Porrello, A. I. Mahmoud, E. Simpson et al., "Transient regenerative potential of the neonatal mouse heart," Science, vol. 331, no. 6020, pp. 1078-1080, 2011.
47. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., "Evidence for cardiomyocyte renewal in humans," Science, vol. 324, no. 5923, pp. 98-102, 2009.
48. J.-O. Jo, S.-R. Kim, M.-K. Bae et al., "Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner," Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1803, no. 11, pp. 1244-1251, 2010.
49. T. Yasukawa, E. Tokunaga, H. Ota, H. Sugita, J. A. J. Martyn, and M. Kaneki, "S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance," The Journal of Biological Chemistry, vol. 280, no. 9, pp. 7511-7518, 2005.
50. E. T. Chouchani, C. Methner, S. M. Nadtochiy et al., "Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I," Nature Medicine, vol. 19, no. 6, pp. 753-759, 2013.
51. H. L. A. Vieira, A.-S. Belzacq, D. Haouzi et al., "The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal," Oncogene, vol. 20, no. 32, pp. 4305-4316, 2001.
52. J. R. Hom, R. A. Quintanilla, D. L. Hoffman et al., "The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation," Developmental Cell, vol. 21, no. 3, pp. 469-478, 2011.
53. N. S. Chandel, "Mitochondria as signaling organelles," BMC Biology, vol. 12, article 34, 2014.
54. L. M. Buja and R. S. Vander Heide, "Pathobiology of ischemic heart disease: past, present and future," Cardiovascular Pathology, vol. 25, no. 3, pp. 214-220, 2016.
55. R. Bretón-Romero and S. Lamas, "Hydrogen peroxide signaling in vascular endothelial cells," Redox Biology, vol. 2, no. 1, pp. 529-534, 2014.
56. M.Y. Lee and K. K. Griendling, "Redox signaling, vascular function, and hypertension," Antioxidants & Redox Signaling, vol. 10, no. 6, pp. 1045-1059, 2008.
57. N. R. Madamanchi and M. S. Runge, "Redox signaling in cardiovascular health and disease," Free Radical Biology and Medicine, vol. 61, pp. 473-501, 2013.
58. 2+ signaling in the myocardium by (redox) regulation of PKA/CaMKII," Frontiers in Pharmacology, vol. 6, article 166, 2015.
59. Y.-S. Zhang, L. He, B. Liu et al., "A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion," Basic Research in Cardiology, vol. 107, no. 3, article 266, 2012.
60. V. Braunersreuther, F. Montecucco, M. Asrih et al., "Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury," Journal of Molecular and Cellular Cardiology, vol. 64, pp. 99-107, 2013.
61. I. Novak, "Mitophagy: a complex mechanism of mitochondrial removal," Antioxidants & Redox Signaling, vol. 17, no. 5, pp. 794-802, 2012.
62. G. W. Dorn, R. B. Vega, and D. P. Kelly, "Mitochondrial biogenesis and dynamics in the developing and diseased heart," Genes & Development, vol. 29, no. 19, pp. 1981-1991, 2015.
63. N. S. Rajasekaran, P. Connell, E. S. Christians et al., "Human α B-crystallinmutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice," Cell, vol. 130, no. 3, pp. 427-439, 2007.
64. A. C. Brewer, S. B. Mustafi, T. V. A. Murray, N. S. Rajasekaran, and I. J. Benjamin, "Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease," Antioxidants and Redox Signaling, vol. 18, no. 9, pp. 1114-1127, 2013.
65. X. Zhang, X. Min, C. Li et al., "Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27," Hypertension, vol. 55, no. 6, pp. 1412-1417, 2010.
66. R. Natarajan, F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler III, "Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury," Circulation Research, vol. 98, no. 1, pp. 133-140, 2006.
67. J. Hu, L. Dong, and C. E. Outten, "The redox environment in the mitochondrial intermembrane space is maintained separately from the cytosol and matrix," The Journal of Biological Chemistry, vol. 283, no. 43, pp. 29126-29134, 2008.
68. P. Korge, G. Calmettes, and J. N. Weiss, "Increased reactive oxygen species production during reductive stress: the roles of mitochondrial glutathione and thioredoxin reductases," Biochimica et Biophysica Acta, vol. 1847, no. 6-7, pp. 514-525, 2015.
69. H. Zhang, P. Limphong, J. Pieper et al., "Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity," The FASEB Journal, vol. 26, no. 4, pp. 1442-1451, 2012.
70. M. Narasimhan and N. S. Rajasekaran, "Reductive potential-a savior turns stressor in protein aggregation cardiomyopathy," Biochimica et Biophysica Acta, vol. 1852, no. 1, pp. 53-60, 2015.
71. G. Morciano, C. Giorgi, M. Bonora et al., "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury," Journal of Molecular and Cellular Cardiology, vol. 78, pp. 142-153, 2015.
72. X.-H. Gao, S. Qanungo, H. V. Pai et al., "Aging-dependent changes in rat heart mitochondrial glutaredoxins-implications for redox regulation," Redox Biology, vol. 1, no. 1, pp. 586-598, 2013.
73. E. L. Holmuhamedov, A. Oberlin, K. Short, A. Terzic, and A. Jahangir, "Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide," PLoS ONE, vol. 7, no. 9, Article ID e44667, 2012.
74. S. Fulda, A.M. Gorman, O. Hori, and A. Samali, "Cellular stress responses: cell survival and cell death," International Journal of Cell Biology, vol. 2010, Article ID 214074, 23 pages, 2010.
75. B. Zingarelli, P. W. Hake, M. O'Connor et al., "Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADPribose) polymerase-1," American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 4, pp. H1408-H1415, 2004.
76. M. Chello, P. Mastroroberto, G. Patti, A. D'Ambrosio, G. Di Sciascio, and E. Covino, "Intermittent warmblood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning," Cardiovascular Surgery, vol. 11, no. 5, pp. 367-374, 2003.
77. G.-Q. Zhong, R.-H. Tu, Z.-Y. Zeng et al., "Novel functional role of heat shock protein 90 in protein kinase C-mediated ischemic postconditioning," Journal of Surgical Research, vol. 189, no. 2, pp. 198-206, 2014.
78. D. Lindholm and U. Arumäe, "Cell differentiation: reciprocal regulation of Apaf-1 and the inhibitor of apoptosis proteins," The Journal of Cell Biology, vol. 167, no. 2, pp. 193-195, 2004.
79. J. Jayakumar, K. Suzuki, M. Khan et al., "Gene therapy for myocardial protection: transfection of donor hearts with heat shock protein 70 gene protects cardiac function against ischemia-reperfusion injury," Circulation, vol. 102, no. 19, supplement 3, pp. III302-III306, 2000.
80. K. Suzuki, Y. Sawa, Y. Kaneda, H. Ichihara, R. Shirakura, and H. Matsuda, "In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat," Journal of Cardiology, vol. 31, no. 3, pp. 187-188, 1998.
81. J. A. Barbour and N. Turner, "Mitochondrial stress signaling promotes cellular adaptations," International Journal of Cell Biology, vol. 2014, Article ID 156020, 12 pages, 2014.
82. T. Masuda, S. Muto, G. Fujisawa et al., "Heart angiotensin IIinduced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy," American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 9, pp.H1871-H1883, 2012.
83. J. Asbun and F. J. Villarreal, "The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy," Journal of the American College of Cardiology, vol. 47, no. 4, pp.693-700, 2006.
84. M. Rajesh, P. Mukhopadhyay, S. Bátkai et al., "Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy," Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 2330-2341, 2009.
85. M. Rajesh, P. Mukhopadhyay, S. Btkai et al., "Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy," Journal of the American College of Cardiology, vol. 56, no. 25, pp. 2115-2125, 2010.
86. M. Rajesh, S. Bátkai, M. Kechrid et al., "Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy," Diabetes, vol. 61, no. 3, pp. 716-727, 2012.
87. S. Raposeiras-Roubín, C. Barreiro-Pardal, E. Álvarez, and J. R. González Juanatey, "Is glycated hemoglobin an accurate enough predictor of subclinicalmyocardial injury or a simple precursor of advanced glycation end products?" Journal of the American College of Cardiology, vol. 60, no. 2, pp. 166-167, 2012.
88. Z. V. Varga, Z. Giricz, L. Liaudet, G. Haskó, P. Ferdinandy, and P. Pacher, "Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy," Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1852, no. 2, pp. 232-242, 2015.
89. Q. Liu, S. Wang, and L. Cai, "Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage," Journal of Diabetes Investigation, vol. 5, no. 6, pp. 623-634, 2014.
90. S. Vedantham, D. Thiagarajan, R. Ananthakrishnan et al., "Aldose reductase drives hyperacetylation of EGR-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals," Diabetes, vol. 63, no. 2, pp. 761-774, 2014.
91. M. Abdillahi, R. Ananthakrishnan, S. Vedanthamet al., "Aldose reductasemodulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion," American Journal of Physiology, vol. 303, no. 3, pp. H297-H308, 2012.
92. V. Srinivasan, A. Radha, S. Ann Marie, and R. Ravichandran, "Aldose reductase, oxidative stress and diabetic cardiovascular complications," Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 10, no. 3, pp. 234-240, 2012.
93. S. D. Funk, A. Yurdagul Jr., and A.W. Orr, "Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes," International Journal of Vascular Medicine, vol. 2012, Article ID 569654, 19 pages, 2012.
94. K. Kaiserova, S. Srivastava, J.D. Hoetker et al., "Redox activation of aldose reductase in the ischemic heart," The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15110-15120, 2006.
95. Y. C. Hwang, M. Kaneko, S. Bakr et al., "Central role for aldose reductase pathway in myocardial ischemic injury," FASEB Journal, vol. 18, no. 11, pp. 1192-1199, 2004.
96. Y. C. Hwang, S. Sato, J.-Y. Tsai et al., "Aldose reductase activation is a key component of myocardial response to ischemia," The FASEB Journal, vol. 16, no. 2, pp. 243-245, 2002.
97. R. Ananthakrishnan, Q. Li, T. Gomes, A. M. Schmidt, and R. Ramasamy, "Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury," Experimental Gerontology, vol. 46, no. 9, pp. 762-767, 2011.
98. N.-H. Son, R. Ananthakrishnan, S. Yu et al., "Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia," PLoS ONE, vol. 7, no. 9, Article ID e46549, 2012.
99. W. H. Tang, S. Wu, T. M. Wong, S. K. Chung, and S. S. M. Chung, "Polyol pathwaymediates iron-induced oxidative injury in ischemic-reperfused rat heart," Free Radical Biology and Medicine, vol. 45, no. 5, pp. 602-610, 2008.
100. K. Shinmura, R. Bolli, S.-Q. Liu et al., "Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning," Circulation Research, vol. 91, no. 3, pp. 240-246, 2002.
101. W. H. Tang, G. M. Kravtsov, M. Sauert et al., "Polyol pathway impairs the function of SERCAand RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins," Journal of Molecular and Cellular Cardiology, vol. 49, no. 1, pp. 58-69, 2010.
102. R. Ananthakrishnan, M. Kaneko, Y. C. Hwang et al., "Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore," American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 2, pp. H333-H341, 2009.
103. J. James and J. Robbins, "Molecular remodeling of cardiac contractile function," American Journal of Physiology, vol. 273, no. 5, part 2, pp. H2105-H2118, 1997.
104. G. K. Savard, N.-H. Areskog, and B. Saltin, "Cardiovascular response to exercise in humans following acclimatization to extreme altitude," Acta Physiologica Scandinavica, vol. 154, no. 4, pp. 499-509, 1995.
105. I. Afanas'ev, "ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?" Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 293769, 13 pages, 2011.
106. M. Ozeki, H. Nagasu, M. Satoh et al., "Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney," Journal of Physiological Sciences, vol. 59, no. 5, pp. 397-404, 2009.
107. S. Givvimani, C. Munjal, R. Gargoum et al., "Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure," Journal of Applied Physiology, vol. 110, no. 4, pp. 1093-1100, 2011.
108. J. G. Travers, F. A. Kamal, J. Robbins, K. E. Yutzey, and B. C. Blaxall, "Cardiac fibrosis: the fibroblast awakens," Circulation Research, vol. 118, no. 6, pp. 1021-1040, 2016.
109. S. Gorressen, M. Stern, A. M. van de Sandt et al., "Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction," PLoS ONE, vol. 10, no. 4, Article ID e0120961, 2015.
110. J. Li, N. Loukili, N. Rosenblatt-Velin et al., "Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo," PLoS ONE, vol. 8, no. 7, Article ID e70331, 2013.
111. C. M. Sag, C. X. C. Santos, and A. M. Shah, "Redox regulation of cardiac hypertrophy," Journal of Molecular and Cellular Cardiology, vol. 73, pp. 103-111, 2014.
112. R. Schulz, M. Kelm, and G. Heusch, "Nitric oxide inmyocardial ischemia/reperfusion injury," Cardiovascular Research, vol. 61, no. 3, pp. 402-413, 2004.
113. P. Mukhopadhyay, M. Rajesh, S. Bátkai et al., "Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro," American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1466-H1483, 2009.
114. Y. Yang, X. Jin, and C. Jiang, "S-glutathionylation of ion channels: insights into the regulation of channel functions, thiol modification crosstalk, and mechanosensing," Antioxidants & Redox Signaling, vol. 20, no. 6, pp. 937-951, 2014.
115. P. Pacher and C. Szabó, "Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes," Current Opinion in Pharmacology, vol. 6, no. 2, pp. 136-141, 2006.
116. D. R. Gonzalez, A. Treuer, Q.-A. Sun, J. S. Stamler, and J. M. Hare, "S-nitrosylation of cardiac ion channels," Journal of Cardiovascular Pharmacology, vol. 54, no. 3, pp. 188-195, 2009.
117. N. Koitabashi and D. A. Kass, "Reverse remodeling in heart failure-mechanisms and therapeutic opportunities," Nature Reviews Cardiology, vol. 9, no. 3, pp. 147-157, 2012.
118. V. R. Pell, E. T. Chouchani, M. P. Murphy, P. S. Brookes, and T. Krieg, "Moving forwards by blocking back-flow: the Yin and yang of MI therapy," Circulation Research, vol. 118, no. 5, pp. 898-906, 2016.
119. A. O. Oyewole and M. A. Birch-Machin, "Mitochondria-targeted antioxidants," The FASEB Journal, vol. 29, no. 12, pp. 4766-4771, 2015.
120. J. W. Walters, D. Amos, K. Ray, and N. Santanam, "Mitochondrial redox status as a target for cardiovascular disease," Current Opinion in Pharmacology, vol. 27, pp. 50-55, 2016.
121. A. H. Talasaz, H. Khalili, F. Fahimi et al., "Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial," American Journal of Cardiovascular Drugs, vol. 14, no. 1, pp. 51-61, 2014.
122. J. Tomé-Carneiro, M. Gonzálvez, M. Larrosa et al., "One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease," American Journal of Cardiology, vol. 110, no. 3, pp. 356-363, 2012.
123. C. Gladine, N. Combe, C. Vaysse et al., "Optimized rapeseed oil enriched with healthy micronutrients: a relevant nutritional approach to prevent cardiovascular diseases. Results of the Optim'Oils randomized intervention trial," Journal of Nutritional Biochemistry, vol. 24, no. 3, pp. 544-549, 2013.
124. J. I. Dower, J. M. Geleijnse, L. Gijsbers, C. Schalkwijk, D. Kromhout, and P. C. Hollman, "Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial," Journal of Nutrition, vol. 145, no. 7, pp. 1459-1463, 2015.
125. M. Castaño, J. M. González-Santos, J. López et al., "Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study," Journal of Cardiovascular Surgery, vol. 56, no. 4, pp. 617-629, 2015.
126. G. A. Kurian, M. Phil, and J. Paddikkala, "Antioxidant status of South Indian patients undergoing coronary artery bypass graft surgery: a role of intra operative magnesium supplementation," International Journal of Cardiology, vol. 128, no. 1, pp. 139-141, 2008.
127. J. S. Petrofsky, M. Laymon, H. Lee et al., "CoQ10 andendothelial function in Asians from Korea compared to Asians born in the United States and US born Caucasians," Medical Science Monitor, vol. 19, no. 1, pp. 339-346, 2013.
128. T. Altaei, "Protective effect of silymarin during coronary artery bypass grafting surgery," Experimental and Clinical Cardiology, vol. 17, no. 1, pp. 34-38, 2012.
129. S. Nishioka, T. Yoshioka, A. Nomura et al., "Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice," Hypertension Research, vol. 36, no. 11, pp. 934-939, 2013.
130. Z.-H. Zhao, J. Shan, M.-X. Xiang, G. Xu, G.-S. Fu, and X.-F. Bao, "Influence of fluvastatin on left ventricular remodeling after myocardial infarction in rats," Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 34, no. 5, pp. 447-464, 2005.
131. K. Takeuchi, T. Omura, M. Yoshiyama et al., "Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats," Heart and Vessels, vol. 14, no. 3, pp. 111-119, 1999.
132. X. Zhou, L. Zhao, J. Mao, J. Huang, and J. Chen, "Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2," Toxicological Sciences, vol. 144, no. 1, pp. 197-203, 2015.
133. D. Bonaduce, M. Petretta, P. Arrichiello et al., "Effects of captopril treatment on left ventricular remodeling and function after anteriormyocardial infarction: comparison with digitalis," Journal of the American College of Cardiology, vol. 19, no. 4, pp. 858-863, 1992.
134. B. Rinaldi, M. Donniacuo, L. Sodano et al., "Effects of chronic treatment with the new ultra-long-acting β2-adrenoceptor agonist indacaterol alone or in combination with the β1-adrenoceptor blocker metoprolol on cardiac remodelling," British Journal of Pharmacology, vol. 172, no. 14, pp. 3627-3637, 2015.
135. H. Murase, A. Kuno, T. Miki et al., "Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats," Cardiovascular Diabetology, vol. 14, no. 1, article 103, 2015.
136. T. Silambarasan, J. Manivannan, M. K. Priya, N. Suganya, S. Chatterjee, and B. Raja, "Sinapic acid protects heart against ischemia/reperfusion injury and H9c2 cardiomyoblast cells against oxidative stress," Biochemical and Biophysical Research Communications, vol. 456, no. 4, pp. 853-859, 2015.